U.S. markets close in 5 hours 46 minutes
  • S&P 500

    4,378.89
    -64.22 (-1.45%)
     
  • Dow 30

    34,512.84
    -356.53 (-1.02%)
     
  • Nasdaq

    14,666.12
    -303.84 (-2.03%)
     
  • Russell 2000

    2,259.99
    -21.01 (-0.92%)
     
  • Crude Oil

    75.62
    +0.17 (+0.23%)
     
  • Gold

    1,735.80
    -16.20 (-0.92%)
     
  • Silver

    22.35
    -0.34 (-1.49%)
     
  • EUR/USD

    1.1682
    -0.0019 (-0.16%)
     
  • 10-Yr Bond

    1.5530
    +0.0690 (+4.65%)
     
  • GBP/USD

    1.3537
    -0.0167 (-1.22%)
     
  • USD/JPY

    111.4500
    +0.4720 (+0.43%)
     
  • BTC-USD

    41,636.56
    -1,921.27 (-4.41%)
     
  • CMC Crypto 200

    1,034.84
    -22.31 (-2.11%)
     
  • FTSE 100

    7,045.08
    -18.32 (-0.26%)
     
  • Nikkei 225

    30,183.96
    -56.10 (-0.19%)
     

Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Teladoc (TDOC) closed at $145.44 in the latest trading session, marking a -0.16% move from the prior day. This change lagged the S&P 500's 0.28% gain on the day.

Heading into today, shares of the telehealth services provider had lost 2.7% over the past month, lagging the Medical sector's gain of 2.77% and the S&P 500's gain of 3.07% in that time.

TDOC will be looking to display strength as it nears its next earnings release. In that report, analysts expect TDOC to post earnings of -$0.63 per share. This would mark a year-over-year decline of 384.62%. Meanwhile, our latest consensus estimate is calling for revenue of $517.06 million, up 79.03% from the prior-year quarter.

For the full year, our Zacks Consensus Estimates are projecting earnings of -$3.53 per share and revenue of $2.02 billion, which would represent changes of -212.39% and +84.35%, respectively, from the prior year.

Investors should also note any recent changes to analyst estimates for TDOC. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 0.66% lower within the past month. TDOC is currently a Zacks Rank #4 (Sell).

The Medical Services industry is part of the Medical sector. This group has a Zacks Industry Rank of 200, putting it in the bottom 22% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Teladoc Health, Inc. (TDOC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.